BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36530709)

  • 1. PrEP stigma among current and non-current PrEP users in Thailand: A comparison between hospital and key population-led health service settings.
    Chautrakarn S; Rayanakorn A; Intawong K; Chariyalertsak C; Khemngern P; Stonington S; Chariyalertsak S
    Front Public Health; 2022; 10():1019553. PubMed ID: 36530709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of attitudes and knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand's Universal Health Coverage implementation.
    Rayanakorn A; Chautrakarn S; Intawong K; Chariyalertsak C; Khemngern P; Olson D; Chariyalertsak S
    PLoS One; 2022; 17(5):e0268407. PubMed ID: 35551288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences and challenges of pre-exposure prophylaxis initiation and retention among high-risk populations: qualitative insights among service providers in Thailand.
    Rayanakorn A; Chautrakarn S; Intawong K; Chariyalertsak C; Khemngern P; Olson D; Chariyalertsak S
    Front Public Health; 2024; 12():1366754. PubMed ID: 38813431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
    Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
    J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand.
    Viriyathorn S; Sachdev S; Suwanwela W; Wangbanjongkun W; Patcharanarumol W; Tangcharoensathien V
    Health Policy Plan; 2023 Nov; 38(Supplement_1):i36-i48. PubMed ID: 37963082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes towards, knowledge about, and confidence to prescribe antiretroviral pre-exposure prophylaxis among healthcare providers in Thailand.
    Wisutep P; Sirijatuphat R; Navanukroh O; Phatharodom P; Werarak P; Rattanasuwan W
    Medicine (Baltimore); 2021 Dec; 100(49):e28120. PubMed ID: 34889271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community awareness of, use of and attitudes towards HIV pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: preparing health promotion for a publicly funded PrEP program.
    Lachowsky NJ; Lawson Tattersall T; Sereda P; Wang C; Edwards J; Hull M
    Sex Health; 2019 Apr; 16(2):180-186. PubMed ID: 31040001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.
    Phanuphak N; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Seekaew P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Na Nakorn PR; Mills S; Avery M; Vannakit R; Phanuphak P
    Sex Health; 2018 Nov; 15(6):542-555. PubMed ID: 30249317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers.
    Kutscha F; Gaskins M; Sammons M; Nast A; Werner RN
    Front Public Health; 2020; 8():298. PubMed ID: 32760688
    [No Abstract]   [Full Text] [Related]  

  • 12. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
    Seekaew P; Nguyen E; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Nakorn PRN; Mills S; Avery M; Vannakit R; Phanuphak P; Phanuphak N
    BMC Public Health; 2019 Mar; 19(1):328. PubMed ID: 30898095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrEP Stigma: Implicit and Explicit Drivers of Disparity.
    Golub SA
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):190-197. PubMed ID: 29460223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.
    Vanhamel J; Rotsaert A; Reyniers T; Nöstlinger C; Laga M; Van Landeghem E; Vuylsteke B
    BMC Health Serv Res; 2020 Jul; 20(1):704. PubMed ID: 32736626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Investigation of Implicit HIV and Preexposure Prophylaxis Stigma: Evidence for Ancillary Benefits of Preexposure Prophylaxis Use.
    Golub SA; Lelutiu-Weinberger C; Surace A
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):264-271. PubMed ID: 29140872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
    Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda.
    Kambutse I; Igiraneza G; Ogbuagu O
    PLoS One; 2018; 13(11):e0207650. PubMed ID: 30475841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of HIV Preexposure Prophylaxis Initiation Among Public Health Clients in Rural and Small Urban Areas in Iowa.
    Howren MB; Francis SL; Polgreen LA; Shafer C; Hoth A; Ohl ME
    Public Health Rep; 2021; 136(2):172-182. PubMed ID: 33108986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
    Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
    J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.